| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 48077-33-4 | 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-Heptadecafluorononyl Methacrylate | C13H7F17O2 |
| 48077-86-7 | 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-Henicosafluoroundecyl Methacrylate | C15H7F21O2 |
| 48077-95-8 | Propenoic Acid 2-[[(3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,10-Heptadecafluorodecyl)Sulfonyl]Methylamino]Ethyl Ester | C16H14F17NO4S |
| 48107-17-1 | (Bicyclo[2.2.1]hepta-2,5-diene)dichlororutheniuM(II) polyMer | |
| 48108-77-6 | (S)-Amino(Phenyl)Acetonitrile | C8H8N2 |
| 48108-93-6 | 2-(2-Aminoethyl)aniline | C8H12N2 |
| 48115-38-4 | alpha-(1-Aminoethyl)-Benzenemethanol | C9H13NO |
| 48120-04-3 | N-(2-Pyridinyl)Hydrazinecarboximidamide | C6H9N5 |
| 48122-13-0 | 1-Methylamino-2,2,6,6-Tetramethylpiperidine | C10H22N2 |
| 48126-31-4 | 5-(Amidinothio)Uracil | C5H6N4O2S |
| 48130-50-3 | Dimethyl(p-vinylbenzyl)sulfonium chloride | C11H15S.Cl |
| 48133-71-7 | 2-[[(2,6-Dichlorophenyl)Methyl]Thio]-Ethanamine | C9H11Cl2NS |
| 48134-75-4 / 39794-99-5 | 1-Methyl-4-Phenyl-Pyridine | C12H12ClN |
| 48140-98-3 | 3,4-Dibromohexahydrophthalic Acid | C8H10Br2O4 |
| 48141-64-6 | [R-(R*,S*)]-alpha-[1-(Ethylmethylamino)Ethyl]Benzyl Alcohol | C12H19NO |
| 48144-44-1 | 1-(3-Chlorophenyl)-3-(Diaminomethylene)Guanidine | C8H10ClN5 |
| 48145-04-6 | 2-Phenoxyethyl acrylate | C11H12O3 |
| 48149-72-0 | Allyl alpha-D-galactopyranoside | C9H16O6 |
| 48150-45-4 | 3-Methacrylamidophenylboronic acid | C10H12BNO3 |
| 48152-09-6 | 1,3-Bis(N-morpholino)propane | C11H22N2O2 |
| 48160-61-8 | 1,1'-(1,4-Phenylene)Bis[2,2-Dihydroxy-Ethanone | C10H10O6 |
| 48162-88-5 | 4-(Benzyloxy)-2-Methylene-4-Oxobutanoic Acid | C12H12O4 |
| 48163-10-6 | 1-Lauroylaziridine | C14H27NO |
| 48172-10-7 | (2S)-4-(1,3-Dioxoisoindolin-2-yl)-2-hydroxybutanoic acid | C12H11NO5 |
| 48173-47-3 | N-Methyl Viloxazine | C14H21NO3 |
| 48174-52-3 | 1,2-Bis(4-vinylphenyl)ethane | C18H18 |
| 48176-62-1 | N-Tosyl-D-Aspartic Acid | C11H13NO6S |
| 48180-65-0 | 1,1'-Oxybis[4-Azido-Benzene] | C12H8N6O |
| 48183-36-4 | 1-(Trimethylsilyl)-1H-Benzotriazole | C9H13N3Si |
| 48187-65-1 / 17617-11-7 | (+)-5,6,7,9,10,14beta-Hexahydro-2-Chloro-5-Methylisoquino[2,1-d][1,4]Benzodiazepine | C18H19ClN2 |
| 48200-75-5 | (3beta,5beta,11beta)-3,11-Dihydroxypregnan-20-One | C21H34O3 |
| 48203-86-7 | 4-Vinyl-N-Cetylpyridinium | C23H40BrN |
| 48208-26-0 | N-Phthaloyl-L-tryptophan | C19H14N2O4 |
| 48209-28-5 | Copper(I) trifluoromethanesulfonate toluene complex | C9H8Cu2F6O6S2 |
| 48212-99-3 | N4-Anisoyl-2'-Deoxycytidine | C17H19N3O6 |
| 48216-85-9 | 3,4-Dibenzoyl Dopamine | C22H19NO4 |
| 48218-81-1 | (2R)-1-[(E)-2-[(2S)-2-Carboxy-6-(Dihydroxymethylidene)-2,3-Dihydro-1H-Pyridin-4-Yl]Ethenyl]-5,6-Dioxo-2,3-Dihydroindole-2-Carboxylic Acid | C18H16N2O8 |
| 48219-88-1 | (9E,11Z,13E)-9,11,13-Octadecatrienoic Acid 2-Benzyl Hydrazide | C25H38N2O |
| 48221-03-0 | 1,1',3,3,3',3'-Hexamethylindodicarbocyanine | C27H31IN2 |
| 48222-46-4 | (9E,11E,13E)-9,11,13-Octadecatrienoic Acid 2-Phenethyl Hydrazide | C26H40N2O |
| 48234-64-6 | Triphenyl(Trityl)Phosphonium Chloride | C37H30ClP |
| 48236-96-0 | Tetrahydroamentoflavone | C30H22O10 |
| 48237-20-3 | Amikacin B | C22H44N6O12 |
| 49537-97-5 | 3-(2-(Diethylamino)Ethyl)-1-(((5-(Methylsulfonyl)-2-Furanyl)Methylene)Amino)-2,4-Imidazolidinedione | C15H22N4O5S |
| 49538-43-4 | 1-Ethyl-2-Piperidinecarboxylic Acid Hydrochloride (1:1) | C8H16ClNO2 |
| 49538-98-9 | Tricyclohexyl[(Diisopropoxythioxophosphoranyl)Thio]Stannane | C24H47O2PS2Sn |
| 49539-13-1 | 5,6,7,8-Tetrahydro-4(1H)-Pteridinone | C6H8N4O |
| 49539-14-2 | 1,5,6,7-Tetrahydro-4-Pteridinamine | C6H9N5 |
| 49539-88-0 | [2-(Trimethoxysilyl)Ethyl]-Benzene | C11H18O3Si |
| 49540-00-3 | Mercury(II) trifluoromethanesulphonate | C2F6HgO6S2 |